Literature DB >> 29956134

Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.

Hua Cao1,2, Jianmei Wu1, Jinhua Zhang3.   

Abstract

Background In response to the recognized difficulty in the management of patients on anticoagulation therapy, anticoagulation management services were developed in both hospital anticoagulation clinics (HACs) and an online anticoagulation clinic (OAC) by a pharmacist. Objective To compare monitoring outcomes and complications of warfarin therapy managed by pharmacists via hospital or on-line. Setting The anticoagulation clinic of Fujian Medical University Union Hospital, China. Method A retrospective, observational cohort study was used to compare patients managed via hospital  to those managed o-line between December 2015 and 2016. The primary outcome was the percentage of time in the therapeutic range (TTR). The secondary outcomes were the incidence rates of hemorrhagic events, thrombotic events and extreme international normalized ratio (INR) values. Results A total of 152 patients were evaluated; 70 patients managed in a HAC were compared to 82 patients managed via an OAC. There were no significant differences in the TTR (78.9 vs. 74.0%, P = 0.393) and adverse events [major bleeding events (0 vs. 1.2%, P = 1.000), minor bleeding events (10.0 vs. 9.8%, P = 0.960), thromboembolic events (0 vs. 0%, P = 1.000), warfarin-related emergency visits (2.9 vs. 3.7%, P = 1.000)], warfarin-related hospital admissions (0 vs. 1.2%, P = 1.000), and the incidence of subtherapeutic (3.0 vs. 3.8%, P = 0.148), and extreme total (8.4 vs. 5.8%, P = 0.135), between the groups managed via HAC and OAC. Patients managed in the HAC were more stable on warfarin, with a higher percentage of INR values within the target therapeutic range (80.2 vs. 71.9%, P = 0.005) and a lower incidence of supratherapeutic INR values (8.4 vs. 18.5%, P = 0.001) compared to patients managed via OAC. Conclusion The management of oral anticoagulation therapy on-line yielded similar clinical outcomes compared to that achieved by management via the hospital, although the incidence of supra-therapeutic INR values was increased.

Entities:  

Keywords:  Anticoagulants; China; International normalized ratio; Pharmacists; Telemedicine; Warfarin

Mesh:

Substances:

Year:  2018        PMID: 29956134     DOI: 10.1007/s11096-018-0674-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  23 in total

1.  Assessing the utility of an online registry for patients monitoring their own warfarin therapy.

Authors:  Deborah McCahon; Jennifer M Baker; Ellen T Murray; David A Fitzmaurice
Journal:  J Clin Pathol       Date:  2015-10-30       Impact factor: 3.411

2.  Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.

Authors:  Fredric W H Chan; Raymond S M Wong; Wing-Hung Lau; Thomas Y K Chan; Gregory Cheng; Joyce H S You
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

3.  Transition of stable patients from traditional anticoagulation clinic services to telephonic management.

Authors:  Brian T Cryder; Margaret A Felczak; Adwoa Darkwa; Hiral Patel; Justine D Janociak; Rami Rihani
Journal:  Int J Clin Pharm       Date:  2017-03-30

4.  Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.

Authors:  Daniel M Witt; Melanie A Sadler; Roberta L Shanahan; Georgann Mazzoli; Donald J Tillman
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

5.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

6.  Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.

Authors:  Jonas Wallvik; Anders Själander; Lars Johansson; Orjan Bjuhr; Jan-Håkan Jansson
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

7.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

8.  Impact of an inpatient anticoagulation management service on clinical outcomes.

Authors:  Paula J Biscup-Horn; Michael B Streiff; Timothy R Ulbrich; Todd W Nesbit; Kenneth M Shermock
Journal:  Ann Pharmacother       Date:  2008-05-06       Impact factor: 3.154

9.  Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.

Authors:  Jürgen H Prochaska; Sebastian Göbel; Karsten Keller; Meike Coldewey; Alexander Ullmann; Heidrun Lamparter; Claus Jünger; Zaid Al-Bayati; Christina Baer; Ulrich Walter; Christoph Bickel; Hugo ten Cate; Thomas Münzel; Philipp S Wild
Journal:  BMC Med       Date:  2015-01-23       Impact factor: 8.775

10.  Telephone-based anticoagulation management in the homebound setting: a retrospective observational study.

Authors:  Samer Hassan; Ali Naboush; Jared Radbel; Razan Asaad; Homam Alkaied; Seleshi Demissie; Terenig Terjanian
Journal:  Int J Gen Med       Date:  2013-12-03
View more
  4 in total

1.  Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting.

Authors:  Jinhua Zhang; Tingting Wu; Wenjun Chen; Jinglan Fu; Xiaotong Xia; Liangwan Chen
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

2.  New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model.

Authors:  Zhihui Zhu; Yuehuan Li; Xu Meng; Jie Han; Yan Li; Kun Liu; Jinglun Shen; Ying Qin; Haibo Zhang
Journal:  BMJ Open       Date:  2019-12-05       Impact factor: 2.692

3.  Effectiveness of the Alfalfa App in Warfarin Therapy Management for Patients Undergoing Venous Thrombosis Prevention and Treatment: Cohort Study.

Authors:  Hua Cao; Shaojun Jiang; Meina Lv; Tingting Wu; Wenjun Chen; Jinhua Zhang
Journal:  JMIR Mhealth Uhealth       Date:  2021-03-02       Impact factor: 4.773

4.  Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study.

Authors:  Shaojun Jiang; Meina Lv; Zhiwei Zeng; Zongwei Fang; Mingrong Chen; Jiafen Qian; Tingting Wu; Wenjun Chen; Jinhua Zhang
Journal:  J Thromb Thrombolysis       Date:  2022-01-29       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.